Tuberculosis (TB) is the leading cause of death from a single infectious agent, requiring at
least 6 months of multidrug treatment to achieve cure 1 . However, the lack of reliable data on …

Background Rapid detection of tuberculosis (TB) among people living with human immunodeficiency
virus (HIV) is a global health priority. HIV‐associated TB may have different clinical …

Background: Effective tuberculosis (TB) control in HIV-prevalent settings is hindered by
absence of accurate, rapid TB diagnostic tests. We evaluated the accuracy of a urine …

Background The lateral flow urine lipoarabinomannan (LF‐LAM) assay Alere Determine™
TB LAM Ag is recommended by the World Health Organization (WHO) to help detect active …

Background. Recent guidelines advocate early antiretroviral therapy (ART) to decrease
human immunodeficiency virus (HIV) morbidity and prevent transmission, but suboptimal …

Since the introduction of azidothymidine in 1987, significant improvements in treatment for
people living with HIV have yielded substantial improvements in global health as a result of …

Effective management of TB requires attention to potential structural, metabolic, vascular,
and infectious complications. In some instances, individualizing treatment regimens may be …

Objective: In settings of high HIV prevalence, tuberculosis control and patient management
are hindered by lack of accurate, rapid tuberculosis diagnostic tests that can be performed at …

Background The World Health Organization has endorsed the use of molecular methods for
the detection of TB and drug-resistant TB as a rapid alternative to culture-based systems. In …

Urinary lipoarabinomannan (LAM) detection is a promising approach for rapid diagnosis of
active tuberculosis (TB). In microbiologically confirmed TB patients, quantitative LAM …